The page is the record's research on the issuer — no analyst, no rating, no view. # Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Arcutis Biotherapeutics, Inc., listed on NASDAQ under ticker ARQT, with ISIN US03969K1088. The LEI is not on the record, because no GLEIF record with the exact legal name in jurisdiction US-DE exists. The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States, Delaware. The segment is not on the record. The issuer's status is listed, not halted. ## The disclosure read The record holds 155 filings in the twelve months from 2025-11-08 to 2026-11-08, across 72 filing days. The median gap between filing days is 2 days. The latest filing is dated 2026-11-04, four days before the record date, and is of type results. The NASDAQ median for filings in the window is 52, with a median cadence gap of 6.0 days and a median latency of 5.0 days. The sector median for 2834 Pharmaceutical Preparations is 63.0 filings, with a median cadence gap of 6.0 days and a median latency of 4.0 days. ## Auditor The auditor of record is Ernst & Young LLP, located in Los Angeles, California. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is zero. ## Open research No openly published research notes were found on the record. The count is zero. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed filings for the issuer in the years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001787306.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/ARQT (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1787306/000178730626000018/arqt-20251231.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/ARQT (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/ARQT · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp